Bolar exemption update will harmonise EU-wide pharma law interpretation

The EU pharmaceutical package and the reform of pharmaceutical legislation is a critical step in making the EU a more attractive location for pharmaceutical manufacturers, and the harmonisation of the so-called ‘Bolar exemption’ plays a key role in that objective.

Read Complete Article

MITLA is a member of the INPLP

    Subscribe for the latest
    IT Law updates

    Receive the latest IT Law updates straight to your inbox, gain access to our exclusive industry events, keep up to date with MITLA.